Mohamed Hamidou Selected Research

Mohamed Hamidou Research Topics

Disease

18	Vasculitis (Vasculitides) 11/2022 - 03/2003
13	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 11/2022 - 01/2012
11	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 11/2022 - 03/2003
9	Microscopic Polyangiitis 01/2020 - 02/2003
7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2024 - 09/2003
6	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2023 - 01/2013
6	Thrombotic Thrombocytopenic Purpura 01/2021 - 01/2012
5	Hemorrhage 01/2023 - 11/2011
5	Infections 10/2019 - 04/2013
4	Arthralgia (Joint Pain) 01/2022 - 12/2007
4	acquired Thrombotic thrombocytopenic purpura 06/2015 - 01/2012
3	Thrombotic Microangiopathies 05/2022 - 02/2014
3	Thrombocytopenia (Thrombopenia) 11/2021 - 06/2016
3	Cytopenia 12/2019 - 04/2017
3	Myositis (Idiopathic Inflammatory Myopathies) 01/2018 - 11/2013
3	Glomerulonephritis 05/2016 - 12/2007
3	Neoplasms (Cancer) 11/2014 - 12/2007
2	Hypertension (High Blood Pressure) 05/2022 - 09/2003
2	Inflammation (Inflammations) 01/2022 - 10/2009
2	Eosinophilia 10/2021 - 01/2020
2	Thrombosis (Thrombus) 10/2021 - 08/2018
2	Mononeuropathies (Mononeuritis Multiplex) 10/2020 - 01/2020
2	Bronchiectasis 10/2020 - 01/2018
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 03/2020 - 03/2003
2	Lymphopenia (Lymphocytopenia) 01/2020 - 11/2014
2	Sepsis (Septicemia) 01/2020 - 11/2014
2	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2019 - 01/2017
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2018 - 08/2018
2	Sarcoidosis (Schaumann Disease) 01/2018 - 04/2014
2	Pathologic Complete Response 01/2018 - 11/2014
2	Lymphoma (Lymphomas) 01/2018 - 03/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 01/2016
2	Immunoglobulin G4-Related Disease 01/2018 - 01/2014
2	Meningitis 01/2018 - 06/2011
2	Anemia 04/2017 - 06/2016
2	Large Granular Lymphocytic Leukemia 03/2016 - 09/2010
2	Takayasu Arteritis (Arteritis, Takayasu's) 11/2015 - 05/2012
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 10/2014 - 11/2011
2	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2014 - 11/2013
2	Antisynthetase syndrome 11/2013 - 12/2012
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2013 - 12/2007
2	Multiple Myeloma 11/2011 - 08/2011
2	Spondylarthropathies 10/2009 - 10/2009
1	Kidney Diseases (Kidney Disease) 01/2023
1	Atypical Hemolytic Uremic Syndrome 05/2022
1	Hemolytic-Uremic Syndrome 05/2022
1	Purpura 01/2022
1	Splenomegaly 10/2021
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 10/2021
1	Ischemic Stroke 10/2021
1	Stroke (Strokes) 10/2021
1	Nephritis 01/2021
1	Hemolysis 01/2021
1	Macular Edema 01/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2020

Drug/Important Bio-Agent (IBA)

19	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 04/2007
17	Rituximab (Mabthera)FDA Link 11/2022 - 01/2012
9	SteroidsIBA 12/2017 - 12/2007
5	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 02/2003
5	thiamine triphosphorate (TTP)IBA 01/2021 - 02/2014
5	AutoantibodiesIBA 05/2019 - 06/2010
4	Inosine Triphosphate (ITP)IBA 01/2023 - 01/2013
4	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 12/2007
4	AntibodiesIBA 01/2018 - 01/2012
4	Azathioprine (Imuran)FDA LinkGeneric 01/2018 - 11/2014
4	Immunoglobulin M (IgM)IBA 01/2016 - 03/2008
3	Thrombopoietin ReceptorsIBA 01/2023 - 08/2018
3	Immunoglobulin G (IgG)IBA 01/2023 - 11/2011
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022 - 02/2003
3	GlucocorticoidsIBA 01/2021 - 02/2003
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018 - 10/2009
3	Immunoglobulin A (IgA)IBA 01/2016 - 08/2011
2	Prednisone (Sone)FDA LinkGeneric 11/2022 - 01/2017
2	Peroxidase (Myeloperoxidase)IBA 01/2022 - 01/2012
2	Imatinib Mesylate (Gleevec)FDA Link 10/2021 - 09/2013
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 03/2020 - 03/2014
2	InterferonsIBA 01/2020 - 01/2020
2	Cladribine FDA LinkGeneric 01/2020 - 08/2015
2	Factor VIII (Coagulation Factor VIII)IBA 05/2019 - 11/2011
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2018 - 02/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2017 - 11/2015
2	Infliximab (Remicade)FDA Link 12/2017 - 05/2012
2	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 11/2013 - 12/2012
2	Antiphospholipid AntibodiesIBA 06/2008 - 09/2003
1	belimumabIBA 04/2024
1	Shiga Toxin (Shigella Toxin)IBA 05/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	P-SelectinIBA 11/2021
1	Ferritins (Ferritin)IBA 10/2021
1	Aligeron (AS 2)IBA 10/2021
1	danaparoid (Orgaran)FDA Link 10/2021
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2021
1	COVID-19 VaccinesIBA 01/2021
1	Arsenic Trioxide (Trisenox)FDA Link 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Interferon-alpha (Interferon Alfa)IBA 01/2020
1	CreatinineIBA 01/2020

Therapy/Procedure

14	Therapeutics 11/2022 - 03/2008
2	Plasma Exchange 01/2021 - 01/2012
2	Duration of Therapy 01/2012 - 02/2003